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Summary 
The activation of natural killer (NK)  cells,  cytotoxic lymphocytes capable of major histocom- 
patibility complex (MHC)-unrestricted  killing and early antiviral defense, is temporally related 
to the  increased  interferon  (IFN)-ix/[3  production  that  is seen in  the  viral infection  of mice. 
Type I  IFN (IFN-ix/[3) are expressed in many cell types early after primary viral infection and 
have been shown to mediate resistance against a variety of viruses. In this study, the role of the 
transcriptional  activator IFN regulatory  factor-1  (IILF-1) in  murine  NK  cell  activity was as- 
sessed.  IP,  F-l-deficient  mice displayed  a  normal frequency  of NK marker-positive  cells,  but 
exhibited greatly reduced NK cell-mediated cytotoxicity after both virus infection and stimula- 
tion with the  IFN inducer polyinosinic:polycytidilic  acid in vivo. In vitro,  cytolytic activity in 
IRF-l-deficient  NK cells remained defective after stimulation  with  IFN-[3,  IL-2, and IL-12. 
IRF-l-deficient mice were unable to eliminate syngeneic MHC  class I-neganve tumor cells in 
vivo, and had a reduced ability to reject parental semi-allogeneic donor cells from the circula- 
non. Thus, IRF-1 as essential for the induction of NK cell-mediated cytotoxicity and for the in 
vivo effector functions that are mediated by this activity. 
N 
'K cells are cytotoxic lymphocytes that are capable of 
lysing a variety of target cells,  including  tumor cells, 
virus-infected  cells,  and  cells  infected  with  intracellular 
bacteria.  NK cell-mediated  killing does not require  previ- 
ous sensitisation  and is MHC  unrestricted  (1),  and as such, 
forms a first line of defense against microbial pathogens  or 
tumor growth.  In the  case  of primary viral refection,  NK 
cell responses are reduced  early and are temporally distinct 
from those  of T  lymphocytes.  The  early response  to viral 
infection  is associated with  increases  in both  systemic  and 
local type  I  IFN  (IFN-ot/[3)  production,  peaking at 3-5  d 
after  infection,  and  closely  mirroring  the  time  course  of 
NK  cell  activation,  blastogenesis,  and  the  augmented  cy- 
tolytic activity that is seen m  viral infection (2). 
IFN regulatory factor-1  (IRF-1), an IFN-inducible  tran- 
scripnonal activator, binds regions within the promoters of 
type I IFNs and several IFN-inducible  genes, and has been 
implicated as a mediator of the  IFN-induced  antiviral state 
(3, 4). IP,.F-1 is constitutively expressed in many cell types, 
and its expression can be strongly enhanced by type I and II 
IFNs, viral infection,  double-stranded ILNA, and cytokines 
such as IL-6 (4,  5). The functional  deletion  of IRF-1  does 
not, however, fully ablate the expression of IFN and IFN- 
inducible  genes. We have previously demonstrated in vitro 
induction  of type I IFN genes by polyinosinic:polycytidylic 
acid  (pI:pC)  and  Newcastle  disease  virus to be  I1LF-1  de- 
pendent  and  independent,  respectively  (6).  In  addition, 
IRF-l-dependent  antiviral  effects of IFNs and  the  course 
of viral infection in IB.F-l-deficient mice have been shown 
to be dependent  on the type of virus investigated  (7), sug- 
gesting  IRF-l~dependent  and  -independent  pathways  in 
the induction  of antiviral states. 
To  clarify  the  role  of I1LF-1  m  NK  cell  function,  we 
have examined the cytolytic activity of NK cells from IRF- 
1-deficient mice in response to lymphocytic choriomenin- 
gitis virus (LCMV)  and pI:pC in vivo, and to IFN-13, IL-2, 
and IL-12 in vitro.  Killing of NK-sensitive targets in vitro 
by spleen  NK cells from IP,  F-l-deficient  mice was found 
to be markedly reduced both after in vivo and in vitro acti- 
vation of NK cells.  A  defect was also evident in the  clear- 
ance  of parental  donor  cells from the  circulation  of I1LF- 
1-deficient  hosts  and  in  the  elimination  of a  syngeneic 
MHC  class I-deficient tumor in vivo, both processes known 
to  be  mediated  by  NK  cells.  Our  results  clearly  indicate 
that IlkF-1 plays a crucial role in the induction  of NK cell- 
mediated cytotoxic and effector functions in vivo. 
Materials  and Methods 
Mice.  C57BL/6 mice deficient in IRF-1 (6) were genotyped 
by genomic  Southern  blotting  of tail  DNA as described previ- 
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C57BL/6  (H-2  b)  IRF-1 +/-  mice  were  bred  with  A/J  (H-2  k) 
IRF-1 -/- mice (kindly provided by Dr. J. Penninger, Amgen In- 
stitute,  Toronto).  Mice were  housed  m  specific pathogen-free 
conchtions, and littermate controls were used within experiments. 
Induction ofNKActivityln  Vivo.  Mice  were  injected with  0.1 
mg i.v. pI:pC  (Pharmacia,  Uppsala, Sweden)  or 2  X  106  PFU 
LCMV (Armstrong strain). After 24 h  (pI:pC) or 72 h  (LCMV), 
spleens were harvested and mononuclear cells (MNC) asolated by 
density gradient centrifugation (Lymphohte M;  Cedarlane, On- 
tario, Canada). 
Induction of NK Activity In Vitro.  Spleen MNC  were  cultured 
in  complete medium  (CM;  ot-MEM  containing  10%  FCS,  20 
mM Hepes, and 10 ~M [3-mercaptoethanol) within 48-well tis- 
sue culture plates at a concentration of 107 cells/ml.  Wells con- 
tained routine rlFN-[3 (Lee Biomolecular Research, San Diego, 
CA) or murine rlL-12 (Genzyme, Cambridge, MA). Plates were 
incubated for 72 h (IFN-[3) or 24 h (IL-12) at 37°C/5% CO2. 
Evaluation of lFN- y in IL- 12-stimulated  Spleen Cultures.  Supema- 
rants were removed from IL-12-stimulated  spleen MNC after a 24-h 
culture, and IFN-y was measured by ELISA (Intertest-y; Genzyrne). 
NK Cytotoxicity Assay.  MNC  were  added  to  V-bottomed 
96-well plates in  CM.  The  NK-sensitive cell line YAC-1  was 
grown an CM, labeled with Na251CrO4 (NEN, Boston, MA; 35 
~Ci/106 cells), and added to wells containing dilutions of MNC. 
Target cell lysis was determined after a 4-h incubation by mea- 
surement of SlCr release using the following formula: percent of spe- 
cific lysis  =  (a  -  b/c  -  b)  X  100%,  where a  =  test release, b = 
spontaneous release, and c =  release in the presence of 1% SDS. 
Spontaneous release was always <10%. 
Analysis oflL-2-stimulated  Cells.  107 spleen MNC were cul- 
tured in CM with 500 U/ml murine rlL-2 in 24-well tissue cul- 
ture plates. Cells were recovered at day 9, washed twice, counted, 
and analyzed by flow cytometfic analysis. 
Tumor Elimination In  Vivo.  Mice  were  injected  subcutane- 
ously in the right flank with 10  s RMA-S cells in 0.1 ml PBS (8). 
Mice were monitored for palpable tumors and were killed when 
tumors reached a diameter of 1 cm. 
Persistence of Parental Donor Cells.  Spleen and  LN  MNC  cells 
were prepared from 6--8-wk-old C57BL/6 (H-2  b) and C57BL/6 X 
A/J  F 1 (H-2  b/k) mice  by density gradient centrifugation.  After 
two washes in CM, the cells were labeled with FITC (Sigma Im- 
munochemicals, St. Louis, MO; 30 p~g/ml in PBS) for 18 rain at 
37°C/5%  CO2.  Excess  FITC  was  removed  by  centrifugation 
through 6% BSA in PBS, and 2  X  107 cells in 0.2 ml PBS were 
injected into the lateral tail vein of rectpient mice (C57BL/6  X 
A/J F1, IRF-1 +/-, or IRF-1-/-). The fate of the donor cells was 
monitored by flow cytometry of peripheral blood and LN cells. 
NK activity was induced in recipient mice by injection of 0.1 mg 
i.p. pI:pC at 1 and 24 h after injecuon of donor cells. 
Flow Cytometric Analysis.  MNC were preincubated with anti- 
Fc~/R mAb (Fc block; Pharn'nngen, San Diego, CA) for 10 rain 
at  room  temperature  and  were  subsequently incubated  on  ice 
with  mAbs  [anta-NKl.1  (PK136,  PE  conjugated),  antl-CD3 
(145-2Cll,  FITC-conjugated),  anti-CD69  (H1.2F3,  biotiny- 
lated), anti-CD25  (7D4, baotinylated), and anti-CDlla (M17/4, 
biotmlyated); all mAbs were from PharMingen (San Diego, CA)] 
for 30 rain in 0.1  ml of PBS containing 1% BSA and 0.1% so- 
dram azide. Cells were washed with PBS and analyzed by flow 
cytometry (FACScalibur  ®,  Becton  Dacklnson &  Co.,  San Jose, 
CA) using CellQuest software (Becton Dickinson). Viable lym- 
phocytes were gated on the basis of forward and side scatter char- 
acteristlcs, and 10,000  gated events were analyzed. 
Results 
NK  Cytotoxidty  in  IRF-I-deficient  Mice  in  Response  to 
LCMVInfection  andpI:pC  Treatment.  The role of IRF-1  in 
the  induction  of  NK  cell  cytotoxicity  in  response  to 
LCMV infection was investigated. 72 h  after high dose in- 
fection with  2  X  106  PFU LCMV,  significant lysis of the 
prototypic  NK-sensitive  cell  line  YAC-1  was  observed 
with  spleen cells from  1RF-1 +/+  mice, but not with  cells 
from  IRF-1 -/-  mice  (Fig.  1 A).  Spleen  cells from  unin- 
fected IRF-I+/+ or IRF-1 -/-  mice  displayed no  measur- 
able lyric activity (data not shown). Stimulation ofNK  lytic 
activity in response  to  the  type I  IFN inducer pI:pC was 
also investigated. 24 h  after administration of 0.1 mg i.v. pI: 
pC,  significant lysis of YAC-1  target cells was  clearly ob- 
served  in  wild-type  mice  (Fig.  1  B).  However,  pI:pC- 
treated  IRF-1 -/-  mice  exhibited markedly  reduced  lytic 
activity compared to wild-type mice, confirming the results 
obtained with LCMV. 
IFN-~8-enhanced  Cytolytic Activity In  Vitro.  To  address the 
possibility that a defect in type I IFN production in IRF-1-/- 
mice was responsible for the lack of cytotoxicity observed 
in IRF-1 -/-  mice, spleen NK cells were incubated in vitro 
with  IFN-[3.  IFN-[3 induced  a  dose-dependent activation 
of NK-mediated lyric activity in Wild-type animals, with a 
maximal  effect  obtained in  the  presence  of 1,000  IU/ml 
IFN-[3 (Fig. 2), as reported previously (9). IRF-l-deficient 
splenocytes demonstrated maximal lytic activity at the same 
dose of IFN-13, but exhibited greatly reduced lyric activity 
compared to wild-type controls. 
IL- 12-enhanced  Cytolytic Activity In  Vitro.  Spleen  MNC- 
derived from IRF-I+/- and IRF-1-/-  mice were incubated 
in the presence of 10 ng/ml IL-12.  Significant lysis of the 
target cell line by IRF-1 +/-  spleen NK cells was  induced 
by IL-12 (Fig. 3 A), while IL-12 failed to augment the cy- 
tolytic activity oflRF-l-deficient NK cells. Analysis of the 
supernatants  from  spleen cells cultured in  the presence  of 
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Figure 1o  In vitro lysis of the NK-sensmve mouse lymphoma YAC-1 
after in vavo  inducuon of  NK cell acUvlty  by (A) LCMV and (~ pl'pC. Pan- 
els show specific  target cell lysis  by IRF-1 +/+ (dosed symbols) and 1RF-1-/- 
(0pen symbols) spleen NK cells. Data is representative of at least eight rmce 
of each genotype exarmned an five separate experlrnents No lytic activity 
was detectable in the absence of induction. 
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Figure 2.  NK-speclfiC  lysas  of YAC-1 target cells after an vxtro mduc- 
tion of NK actlvaty by IFN-[$. Black bars represent lysls by IRF-1  +/- 
spleen NK cells, and white bars represent lysis by IP,.F-1  -/- spleen NK 
cells at an E/T rano of 100.1. Data are shown as mean + SEM for a single 
experiment performed in quadruplicate in which cells from two mace of 
each genotype were pooled, and are representative of two experiments. 
10 ng/ml IL-12 revealed a defect in IFN-~/production in 
IRF-1-/--derived spleen cells (Fig. 3  B). 
IL-2-stimulated  Proliferation and  Cytolytic Activity  In  Vitro. 
Incubation in the presence of 500 U/ml IL-2 for 9 d induced 
preferential proliferation of NK cells, with NK1. I+/CD3 - 
cells  comprising  61.2  +  1.2%  of recovered  IRF-1 +/-- 
derived cells, compared to 44.5  +  3.6% in the case oflRF- 
I-/--derived spleen cells (mean  +  SEM for three mice in 
each group). Both IP,  F-1 +/--  and I1LF-1-/--derived cells 
contained  approximately equal  percentages  (2.5-3.0%)  of 
NKI.I+/CD3-  cells at the start of the 9-d culture. Calcu- 
lation of absolute numbers  of NKl.1 +  and CD3 +  cells re- 
vealed a  more profound  deficit in  IP,.F-1-/--derived NK 
cell proliferation in response to IL-2 (Fig. 4  B), with a five- 
fold decrease in viable NKI.1 +  cells present after 9  d. The 
cytolytic activity of day  9  IL-2-stimulated NK  cells was 
evaluated against YAC-1 target cells (Fig. 4  C) and revealed 
that  although  IlkF-1 -/-  LAK cells  are  clearly capable  of 
YAC-l-directed cytolytic activity, their lytic activity is re- 
duced compared to IRF-I+/-  controls. 
Tumor Elimination  In  Vivo.  Wild-type  and  Ii:l,F-1--defi- 
cient  mice  were  injected subcutaneously with  105  RMA-S 
cells. 1LMA-S  ceils have  been  shown  to  be  eliminated in 
mice with fully functional NK cells, while mice deficient in 
NK  ceil-mediated  cytotoxicity  are  unable  to  clear  105 
RMA-S  ceils (8,  10). No palpable tumors were detected in 
wild-type mice  during the  experiment  (20  d),  but  tumor 
growth  developed  in  all  IP,.F-l-deficient mice  between 
days 12 and 15 (Fig. 5). 
Persistence of Parental Donor Cells  in the  Circulation  of IRF- 
1-deficient Mice.  It is known that rejection of a parental bone 
marrow graft in F1 recipients is mediated by NK ceils that 
are activated by the absence of the fiall complement of MHC 
class I  molecules (11).  To investigate this hybrid resistance 
in  IRF-l-deficient mice,  FITC-labeled F1  (C57BL/6  × 
A/J,  H-2  b/k) or  C57BL/6  (H-2  b)  cells were  injected into 
the circulation ofF1 IRF-I+/- and IlkF-1-/- mice (H-2b/k). 
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Figure  3.  IL-12-augmented  lysxs of YAC-1  target cells, and IL-12- 
dependent  IFN-~, production  is defective m  IP,  F-l-deficlent rmce in 
vitro  IL-12 mmulates sigmficant lysis  of YAC-1 target cells in IRF-1 +/- 
rmce, while cytolync acnvlty is defective in IlkF-1  -/- mace (A). Two 
rmce of each genotype are shown (closed symbols represent heterozygous 
control effector cells, open symbols represent homozygous IP,  F-l-defi- 
caent effector cells), representative of sxx animals examaned m three other 
expenments. Analysis  of supematants taken from IL-12~nmulated  spleen 
cell culture (10 ng/ml) revealed a defect m IFN-~/production  (B)  Black 
bars represent IFN-~/producnon  by I1LF-1  +/- mice, and white bars rep- 
resent IRF-1 -/  mace. Data are shown as mean + SEM of an experiment 
with two mace m each group performed an tnphcate, and are representa- 
rive ofsax ammals. 
NK activity was induced in recipient mice by the injection 
ofpI:pC at the time of donor cell injection and at 24 h  after 
injection.  Persistence  of FITC-labeled donor  cells in  the 
LN  of recipient animals was  followed by flow cytometry 
(Fig.  6).  While  F 1 syngeneic  donor  cells  persisted  in  F1 
hosts,  C57BL/6-derived parental donor  ceils (H-2  b)  were 
eliminated in F1 IP,-F-1 +/- mice. In contrast, F1  I1LF-1 -/- 
mice were unable to eliminate the parental donor cell graft. 
Normal Numbers and Surface Markers  of lRF-1 -/-  NK1.1 + 
NK Cells.  The potential role of IRF-1  in the ontogeny 
and  activation of murine  NK  cells was  addressed by flow 
cytometric  analysis  of spleen  MNC  that  were  obtained 
from pI:pC-treated mice (Fig. 7). No significant difference 
in  the  number  of NKI.I+/CD3  -  cells  was  evident  be- 
tween heterozygous and homozygous IP,  F-1--deficient mice, 
and  the  number  of CD3-/NKI.1  +  cells  expressing  the 
early activation marker CD69 was similar in both groups of 
mine.  Comparable  numbers  of CD3-/NKI.1  +  cells  also 
expressed  the  oL  chain  of the  IL-2  receptor  (CD25)  and 
CDlla,  the ot  chain of LFA-1, in both  heterozygous and 
homozygous IP,  F-l-deficient mice (data not shown). 
Discussion 
From  the  data  presented  in  this  study,  it  is  clear  that 
IP,  F-1 plays an essential role in the augmented lytic activity 
of murine  NK  cells after viral infection,  stimulation with 
type  I  IFNs,  or stimulation with  IL-12.  Flow cytometric 
analysis of spleen MNC  from heterozygous and homozy- 
gous  IRF-l-deficient mice  indicates that  IILF-1  does not 
play a role in the ontogeny of NK cells, and that the defect 
seen in  NK cell-mediated cytotoxicity is not  caused by a 
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Figure  4.  IL-2-snmulated proliferation and augmented  kllhng  of NK 
cells is pamally impaired in IR.F-l-defioent mice  During a 9-d culture 
of spleen cells m the presence of 500 U/ml IL-2, NKI.I+/CD3  cells 
proliferate  preferentially.  (A)  FACS  ® analysis (with  the  percent  of 
NKI.1 + and CD3 ÷ cells shown in thmr respecnve quadrants) of day 9 
IL-2~sumulated  cells from  single representative  heterozygous  and ho- 
mozygous IRF-l-deficlent nuce, selected from three  of each genotype 
that was examined in this experiment. Absolute numbers of NK 1.1 + and 
CD3 + cells at day 9 (B) were determined from total wable cell counts and 
the percent of cells obtained from  FACS  ® analysis. Solid bars represent 
ceils from heterozygous trace, while open bars represent cells from ho- 
mozygous IR.F-l-deficlent  nuce. Data are shown as the mean number of 
viable cells -+ SEM for three mice in each group. Lytlc acnwty of day 9 
IL-2-stimulated cells was assessed using YAC-1  target cells (C). E/T ra- 
nos were  calculated usmg'alSsolute numbers of wable  NKI.I+/CD3 
cells present, m the killing assay. Data are shown as percent specific lysls by 
NK cells derived'from two  IRF-1 +/  (solid symbols)  and two IR.F-1  -/- 
(open symbols)  inlce. 
lack of NK  celR: In addition, the expression of the surface 
molecules CD25,'CD69,  and LFA-1 by NK cells was simi- 
lar  in  ItkF-l-deficient  mice  compared  to  heterozygous 
control mice. 
One explanation for our findings is that an inherent de- 
fect  in the  prodfiction  of type  I  IFNs  exists  in  IRF-1 -/- 
mice, leading to the insufficient activation of NK cells. The 
absolute role  of IP,  F-1  in the  induction of type  I  IFNs is 
controversial, and the effect of lRF-1  deficiency on type I 
IFN production remains unclear. IP,.F-1 has been shown to 
bind regions within the promoter of type I IFNs (3, 4), and 
overexpresslon  of IRF-1  results  in  IFN-~  production  in 
some cell lines (4,  12). However, although the induction of 
type  I  IFN mRNAs  by pI:pC has been shown to  be dra- 
matically reduced  in  vitro  in  IRF-l-deficient  embryonic 
fibroblasts compared  to  wild-type controls  (6),  Reis  et  al. 
have  shown  that  in vivo,  pI:pC  injection does  not reveal 
any significant difference  in IFN-ot  or  IFN-~3 production 
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Figure 5.  Ehmlnanon of MHC class I-negative syngeneic tumor is Ira- 
paired in IRF-l-deficient mice. IRF-1 +/+  (closed symbols)  and IRF-1  '- 
(open symbols)  mice were injected subcutaneously with 105 RMA-S cells 
and momtored for palpable tumors. Five age- and sex-matched rmce were 
analyzed in each group 
between wild-type and IRF-l-deficient mice  (13).  In our 
study,  the  addition of exogenous  IFN-~  to  spleen ceils in 
vitro  clearly  does  not  fully  restore  the  lytic  activity  of 
IRF-1  /- NK ceils to that seen in wild-type ceils. This im- 
plies that the diminished NK activity seen upon in vxvo in- 
duction may not be caused by a  defect in type I  IFN pro- 
duction,  and  that  other  factors  intrinsic to  NK  ceils  and 
essential for lytic activity are disrupted in IRF-1-/-  mice. 
IL-12 was first identified as an inducer of NK ceil-medi- 
ated  cytotoxicity  (14),  presumably  through  the  induction 
of genes  involved in  target  cell  lysis,  such  as  perforin  or 
granzyme B  (15).  Another important function of IL-12  is 
the reduction of IFN-~/production in resting and activated 
NK cells (16), a key step in the innate response to acute in- 
fection.  In this study, we  report that  IRF-l-deficient NK 
cells  are  incapable  of responding  appropriately  to  IL-12 
stimulation in vitro, since both enhanced lyric activity and 
IFN-y production are defective in splenocytes derived from 
IkF-1 -/-  mice. Our data suggest that IL-12-mediated sig- 
naling itself is defective in the NK  ceils of IR.F-l-deficient 
mice, correlating with a  recent report that  IL-12-deficlent 
mice exhibit a defect in both NK cell cytolytic activity and 
IFN-y production (17). IL-12 has also been implicated as a 
central  mediator  of acute  GVHD  in BDF 1 mice  injected 
with B6  donor splenocytes.  Neutralization of endogenous 
IL-12  moderated  acute  GVHD  and  resulted  in  decreased 
splenic NK activity and IFN-y production (18). We there- 
fore postulate that the defective rejection ofsemlailogenelc, 
hematopoetic  donor cells by IRF-1 -/  mice is,  at least in 
part, the result of aberrant IL-12-mediated signaling. 
The functional response of NK  cells to IL-2 stimulation 
in vitro was also found to be disrupted in IP,.F-1 knockout 
mice. Both proliferation and augmentation of lytic activity 
of IL-2-stimulated NK  cells were  defective,  although  the 
partial  reduction  in lytic  activity seen  in  IRF-1 -/-  com- 
pared to IR.F-1 +/- controls was not as profound as that seen 
after activation with type I IFNs or IL-12. It appears, there- 
fore, that IL-2-mediated effects on NK cell function are not 
fully dependent on IP,  F-1. 
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Figure 6.  Persistence of parental lymphmd donor cells  m IRF-1 +/  and 
IRF-1  /- mace. (C57BL/6 ×  A/J) F  1 I1LF-1  +/- (left panels)  or IIkF-1  -/- 
(right panels)  mice were injected mtravenously wxth either 2 ×  107 FITC- 
labeled (C57BL/6 × A/J) F1 (F1, upper panels)  or C57BL/6 (B6, lowerpan- 
e/s) parental donor ceils. 3 d later, LN cells were analyzed for the persis- 
tence of FITC-labeled cells by flow cytometry. Figures m bold type show 
the percentage of perslsung donor cells for single representatwe ammals, 
selected from six per group. Identical results were obtained m spleen and 
penpheral blood cells (data not shown). 
The expression of some genes is critically dependent on 
IILF-1, for example, reducible nitric oxide synthase (iNOS) 
or guanylate-binding protein (19). It has recently been sug- 
gested that NO  may play a  role in human  NK cell-medi- 
ated cytotoxicity (20), and given the dependence of iNOS 
on  IR.F-1  for induction,  the  possibility that  the  defect in 
NK cell-mediated cytotoxicity in I1LF-1 -/  mice is caused 
by the reduced production of NO  was addressed in our lab- 
oratory.  The  nonspecific NO  synthase  inhibitor N-mono- 
methyl-L-arginine  and  the  iNOS-specific  inhibitor  ami- 
noguanidine exhibited no inhibitory effect (at doses ranging 
from  10  nM  to  1  raM)  on pI:pC-induced, NK-mediated 
killing of YAC-1  target  cells  in  vitro  (data  not  shown). 
This  suggests  that  NO  does  not  play a  role  in  NK  cell- 
mediated  cytotoxicity, and  supports  the  finding that  per- 
forin  is  predominately  responsible  for  NK  cell-mediated 
cytotoxicity (21, 22). 
The  expression of many IFN-inducible genes is mediated 
through  IR.F-l-independent pathways,  including double- 
stranded  RNA-dependent  protein  kinase  and  2'-5'  oli- 
goadenylate synthetase  (6).  It  is  possible that  the  residual 
NK-mediated lytic activity of IRF-1 -/-  cells observed in 
our  experiments  may be  mediated via other  transcription 
factors.  Candidates  include  IFN-~/-inducible  y-activated 
factor, via its association with the IFN-',/activation site, or 
IFN-stimulated gene factor 3  (ISGF3), which shares over- 
~  .-  LTg 
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Figure  7.  Flow  cytometrlc analysis of spleen lymphocytes obtained 
from pI:pC-treated IRF-1 +/- and IRF-1-/- littermate trace. Numbers m 
bold type indicate the percentage of NK1.1 +/CD3- cells (left panels)  and 
NK1.1+/CD69 + cells (right panels)  for single representative mice. Slrmlar 
results were obtained in other analyses  of at least five animals  of each gen- 
otype in two separate expenments. 
lapping sequence recognition with I1LF-1, and may coop- 
erate with IRF-1 in the induction of type I  IFN-inducible 
genes in a  nonredundant  fashion  (23).  Although NK  cells 
both  produce  and  respond  to  IFN-~/,  experiments  using 
IFN-~/-deficient mice show that enhanced splenic NK cell 
activity from pI:pC-treated mice is independent of type II 
IFN,  and that induction of type I  IFNs can at least com- 
pensate for an absence of IFN-"~ (24). 
The data obtained an our in vivo studies of hybrid resis- 
tance to a hematopoietic graft, as well as the rejection of an 
MHC  class I-negative tumor cell from a peripheral site of 
injection, confirm the in vitro data showing a lack of NK 
cell-mediated cytotoxicity in IRF-1-/-  mice. While type I 
IFNs were  induced in the in vitro models of NK  activity 
by biological response modifiers, the rejection ofallogeneic 
grafts and MHC  class I-negative tumor cells are models for 
which  the  role  of endogenous  IFNs remains to be  eluci- 
dated.  Our  data  does,  at  least indirectly, support  findings 
that IL-12 plays a prominent role in the acute rejection of 
hematopoetlc allografts and MHC  class Iynegative cells in 
the mouse. 
In  conclusion,  the  absence  of the  transcription  factor 
IRF-1  leads  to  a  defect in  NK  cell cytolytic activity in- 
duced in response to LCMV infection, pI:pC, IFN-[3, IL-12, 
or IL-2, which is not the result of reduced NK cell num- 
ber, or of NK cell activation as assessed by the expression of 
the  activation  markers  CD69  and  CD25.  In  addition, 
MHC  class I-deficient tumor cells are not eliminated, and 
clearance of parental donor cells is impaired in IRF-l-defi- 
cient mice. IRF-1 is therefore an essential mediator of nor- 
mal NK cell function in the mouse. 
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